Technology

Amid economic uncertainty, TruStage reports over $6.1B in revenue, climbs life insurance ranks, and deepens its fintech and community investments.

A university-born startup has won a major award for its groundbreaking technology that promises a cheaper, more effective way to remove toxic PFAS.

Shareholder Plantro Ltd. calls for the sale of Ag Growth International, citing poor performance and a flawed turnaround plan after a dismal Q4 report.

With near-zero revenue and a history of pivots, 1606 Corp. is betting its future on solving AI's energy crisis. Can it pull off this risky venture?

Most business owners don't know how to sell. A new guide from an investment banker aims to change that with a practical, step-by-step playbook.

Heathos' new platform targets a major gap in the insurance market, but can it overcome industry hurdles and a troubled reputation for its existing brands?

The new platform centralizes historical trade records, aiming to streamline broker workflows amid rising market complexity and a surge in digital tool adoption.

With revenues up but losses widening, Arverne Group is aggressively investing in geothermal energy and lithium to secure France's energy independence.

After a standout debut at CES 2026, the emotionally intelligent robot OlloNi is heading to Kickstarter. Can it turn industry buzz into a new reality?

Global Battery Materials ships its first graphite samples and opens a Quebec lab, a major step toward a secure, ex-China battery supply chain for North America.

A new coalition of tech and healthcare leaders aims to help rural hospitals access a massive $50B federal fund and transform care for good.

Early data for VG801 shows vision improvement in Stargardt disease patients, leveraging novel tech and fast-track FDA support to tackle a leading cause of blindness.

A scathing report from Spruce Point Capital alleges Bunge's massive Viterra deal has failed, exposing deep financial strain and questionable accounting.

SciTech's ST-001 overcomes a decades-old barrier for fenretinide, showing promising results for Cutaneous T-Cell Lymphoma patients in early trials.

A unique partnership between a debt acquirer and a top charity is pushing for major UK financial inclusion reform from within the House of Lords.

Bessor Minerals abruptly terminates its Jagrite Graphite Project deal, raising questions about its strategy and the volatile critical minerals market.

With €10M in new funding, Berlin-based Cellbricks is moving its biofabricated human tissues from lab to preclinical trials, promising a new era for patients.

A new regulated platform from STS Digital, backed by Kraken, unlocks sophisticated investment strategies across 400+ digital assets for institutions.

HBT Financial adds 40-year banking veteran Michael Morton to its board, a strategic move signaling a focus on commercial growth and risk management.

As cyberattacks increasingly target user identities, ID Dataweb's award-winning platform highlights a new defense that verifies trust without friction.